The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Overall response rate as a surrogate of progression-free survival with molecular targeted agents: A meta-analysis of phase III trials in advanced non-small cell lung cancer.
 
Hiroaki Akamatsu
No Relationships to Disclose
 
Keita Mori
No Relationships to Disclose
 
Takashi Kikuchi
No Relationships to Disclose
 
Hiroki Ueda
No Relationships to Disclose
 
Keiichiro Akamatsu
No Relationships to Disclose
 
Masanori Nakanishi
No Relationships to Disclose
 
Yasuhiro Koh
No Relationships to Disclose
 
Kazuto Matsunaga
No Relationships to Disclose
 
Nobuyuki Yamamoto
Speakers' Bureau - AstraZeneca; Boehringer Ingelheim; Chugai Pharma; Lilly; Pfizer